JP4191825B2 - ５−アミノイソキサゾール誘導体 - Google Patents

５−アミノイソキサゾール誘導体 Download PDF

Info

Publication number
JP4191825B2
JP4191825B2 JP27246798A JP27246798A JP4191825B2 JP 4191825 B2 JP4191825 B2 JP 4191825B2 JP 27246798 A JP27246798 A JP 27246798A JP 27246798 A JP27246798 A JP 27246798A JP 4191825 B2 JP4191825 B2 JP 4191825B2
Authority
JP
Japan
Prior art keywords
group
isoxazole
pyridyl
fluorophenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP27246798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000086657A5 (enExample
JP2000086657A (ja
Inventor
信義 南
通隆 佐藤
幸市 蓮見
則夫 山本
勝幸 慶野
照明 松井
有弘 金田
修治 太田
教久 斎藤
秀一郎 佐藤
章 朝烏
知 土井
基博 小林
潤 佐藤
創 浅野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Aska Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aska Pharmaceutical Co Ltd filed Critical Aska Pharmaceutical Co Ltd
Priority to JP27246798A priority Critical patent/JP4191825B2/ja
Publication of JP2000086657A publication Critical patent/JP2000086657A/ja
Publication of JP2000086657A5 publication Critical patent/JP2000086657A5/ja
Application granted granted Critical
Publication of JP4191825B2 publication Critical patent/JP4191825B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP27246798A 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体 Expired - Lifetime JP4191825B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27246798A JP4191825B2 (ja) 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27246798A JP4191825B2 (ja) 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体

Publications (3)

Publication Number Publication Date
JP2000086657A JP2000086657A (ja) 2000-03-28
JP2000086657A5 JP2000086657A5 (enExample) 2005-10-20
JP4191825B2 true JP4191825B2 (ja) 2008-12-03

Family

ID=17514333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27246798A Expired - Lifetime JP4191825B2 (ja) 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体

Country Status (1)

Country Link
JP (1) JP4191825B2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016311A1 (en) * 2000-08-22 2002-02-28 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
WO2002020462A1 (en) * 2000-09-01 2002-03-14 Ono Pharmaceutical Co., Ltd. Benzoic acid derivatives and drugs containing the same as the active ingredient
DE60122176T2 (de) * 2000-09-15 2007-07-05 Vertex Pharmaceuticals Inc., Cambridge Isoxazole und ihre verwendung als erk-inhibitoren
JP2004521892A (ja) * 2000-12-20 2004-07-22 メルク　エンド　カムパニー　インコーポレーテッド （ハロ−ベンゾカルボニル）複素環縮合フェニル系ｐ３８キナーゼ阻害剤
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
AU2003245989A1 (en) 2002-07-09 2004-01-23 Boehringer Ingelheim Pharma Gmbh And Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
BRPI0516595A (pt) 2004-10-16 2008-09-23 Astrazeneca Ab processo para fabricar um composto, e, composto
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
ATE538118T1 (de) * 2004-12-28 2012-01-15 Aska Pharm Co Ltd Pyrimidinylisoxazolderivat
NZ560712A (en) 2005-02-17 2010-12-24 Synta Pharmaceuticals Corp (3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
KR20110084339A (ko) 2005-07-09 2011-07-21 아스트라제네카 아베 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한 헤테로아릴 벤즈아미드 유도체
JP5324785B2 (ja) 2005-10-28 2013-10-23 武田薬品工業株式会社 複素環アミド化合物及びその用途
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
EP1975158B9 (en) * 2005-12-27 2012-02-29 Universidad Del Pais Vasco-Euskal Herriko Unibersitatea Novel pyrrole derivatives with histone deacetylase inhibitor activity
US20090192164A1 (en) * 2006-06-28 2009-07-30 Aska Pharmaceutical Co., Ltd. Treating agent of inflammatory bowel disease
JP5244591B2 (ja) * 2006-06-28 2013-07-24 あすか製薬株式会社 ピリジルイソオキサゾール誘導体
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
TW200825060A (en) 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
MX2009006729A (es) 2006-12-21 2009-08-07 Astrazeneca Ab Nuevo compuesto cristalino util como activador de glk.
KR101434706B1 (ko) 2007-02-16 2014-08-26 아스카 세이야쿠 가부시키가이샤 미립자 유성 현탁액을 포함하는 의약 조성물
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
KR20100037600A (ko) * 2007-06-13 2010-04-09 브리스톨-마이어스 스큅 컴퍼니 응고 인자 억제제로서의 디펩티드 유사체
MX2011001333A (es) 2008-08-04 2011-03-15 Astrazeneca Ab Derivados de pirazolo [3, 4] pirimidin-4-ilo y sus usos para tratar la diabetes y obesidad.
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
WO2010116176A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
US11576914B2 (en) 2017-07-26 2023-02-14 The Doshisha Drug for treating or preventing disorder caused by TGF-β signaling, and application thereof

Also Published As

Publication number Publication date
JP2000086657A (ja) 2000-03-28

Similar Documents

Publication Publication Date Title
JP2000086657A (ja) ５−アミノイソキサゾール誘導体
JP4632544B2 (ja) アミノピラゾール誘導体
KR102420262B1 (ko) 신규한 퀘르세틴 리독스 유도체 및 bet 억제제로서의 용도
KR102420263B1 (ko) 신규한 퀴나졸린 리독스 유도체 및 bet 억제제로서의 용도
JP5119157B2 (ja) カゼインキナーゼｉｉ（ｃｋ２）モジュレーターとしてのピラゾロ−ピリミジン類
US8877944B2 (en) 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors
JPWO2000039116A1 (ja) アミノピラゾール誘導体
EP0526348B1 (fr) Dérivés d'indoline portant une fonction amidique, leur préparation, les compositions pharmaceutiques en contenant
JPH11335375A (ja) ヒストン脱アセチル化酵素阻害作用を有するベンズアミド誘導体
JP5634263B2 (ja) キナゾリンジオンキマーゼ阻害剤
KR102404865B1 (ko) 항종양제
EP3204006A2 (en) Induction of gata2 by hdac1 and hdac2 inhibitors
JP2015071622A (ja) 医薬品
JP2010508288A (ja) キナーゼ阻害剤として有用なヘテロサイクリックアミド化合物
US9120780B2 (en) Indole or indazole derivative or salt thereof
JP2005519074A (ja) 治療用の置換インダゾール誘導体
JP2002088073A (ja) 抗アンドロゲン剤
JP5244591B2 (ja) ピリジルイソオキサゾール誘導体
WO2016120850A9 (en) Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof
JPWO2009123080A1 (ja) インドリノン化合物
US20250221977A1 (en) Novel benzothiophene derivative and use thereof as bet inhibitor
JP4550353B2 (ja) 造血器型プロスタグランジンｄ２合成酵素阻害剤
JPWO2008001929A1 (ja) 炎症性腸疾患の処置剤
CN115784991B (zh) N-(苯磺酰基)酰胺衍生物及其制备方法和用途
JP5424187B2 (ja) アシルアミノフェニル基を有する抗がん剤

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050620

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080126

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080624

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080916

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080919

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110926

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110926

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120926

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120926

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130926

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term